Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIMIGRAINE DRUG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Williamson, DJ; Hargreaves, RJ
      Neurogenic inflammation in the context of migraine

      MICROSCOPY RESEARCH AND TECHNIQUE
    2. Goadsby, PJ; Akerman, S; Storer, RJ
      Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex

      ANNALS OF NEUROLOGY
    3. Carruthers, AM; Sellers, LA; Jenkins, DW; Jarvie, EM; Feniuk, W; Humphrey, PPA
      Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons

      MOLECULAR PHARMACOLOGY
    4. Bingham, S; Davey, PT; Sammons, M; Raval, P; Overend, P; Parsons, AA
      Inhibition of inflammation-induced thermal hypersensitivity by sumatriptanthrough activation of 5-HT1B/1D receptors

      EXPERIMENTAL NEUROLOGY
    5. Goadsby, PJ; Hargreaves, RJ
      Mechanisms of action of serotonin 5-HT1B/1D agonists: Insights into migraine pathophysiology using rizatriptan

      NEUROLOGY
    6. Gupta, P; Butler, P; Shepperson, NB; McHarg, A
      The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT1B/1D receptor agonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Tfelt-Hansen, P; De Vries, P; Saxena, PR
      Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy

      DRUGS
    8. Nagain-Domaine, C; Presset, O; Chariot, J; Roze, C
      Effect of sumatriptan on external pancreatic secretion and its interactionwith endogenous norepinephrine in the rat

      PANCREAS
    9. Razzaque, Z; Heald, MA; Pickard, JD; Maskell, L; Beer, MS; Hill, RG; Longmore, J
      Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Hara, H; Shimazawa, M; Sasaoka, M; Yamada, C; Iwakura, Y; Sakai, T; Maeda, Y; Yamaguchi, T; Sukamoto, T; Hashimoto, M
      Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    11. Cutrer, FM; Yu, XJ; Ayata, G; Moskowitz, MA; Waeber, C
      Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis

      NEUROPHARMACOLOGY
    12. Baezner, H; Steinke, W; Daffertshofer, M; Hennerici, M
      Vasoneuronal coupling in migraineurs after subcutaneous sumatriptan: a TCDstudy

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    13. John, GW; Pauwels, PJ; Perez, M; Halazy, S; Le Grand, B; Verscheure, Y; Valentin, JP; Palmier, C; Wurch, T; Chopin, P; Marien, M; Kleven, MS; Koek, W; Assie, MB; Carilla-Durand, E; Tarayre, JP; Colpaert, FC
      F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    14. Goadsby, PJ
      Understanding migraine pathophysiology through studying the mechanism of action of rizatriptan

      HEADACHE
    15. Gupta, P; Scatchard, J; Napier, C; McHarg, A; Wallis, R
      Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Longmore, J; Razzaque, Z; Shaw, D; Davenport, AP; Maguire, J; Pickard, JD; Schofield, WN; Hill, RG
      Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. GOADSBY PJ; HOSKIN KL; KNIGHT YE
      SUBSTANCE-P BLOCKADE WITH THE POTENT AND CENTRALLY ACTING ANTAGONIST GR205171 DOES NOT EFFECT CENTRAL TRIGEMINAL ACTIVITY WITH SUPERIOR SAGITTAL SINUS STIMULATION

      Neuroscience
    18. LEGRAND B; VIE B; JOHN GW
      EFFECTS OF SUMATRIPTAN ON CORONARY FLOW AND LEFT-VENTRICULAR FUNCTIONIN THE ISOLATED-PERFUSED GUINEA-PIG HEART

      Journal of cardiovascular pharmacology
    19. ENNIS MD; GHAZAL NB; HOFFMAN RL; SMITH MW; SCHLACHTER SK; LAWSON CF; BINIM W; PREGENZER JF; SVENSSON KA; LEWIS RA; HALL ED; SUTTER DM; HARRIS LT; MCCALL RB
      ISOCHROMAN-6-CARBOXAMIDES AS HIGHLY SELECTIVE 5-HT1D AGONISTS - POTENTIAL NEW TREATMENT FOR MIGRAINE WITHOUT CARDIOVASCULAR SIDE-EFFECTS

      Journal of medicinal chemistry
    20. CUTLER NR; SALAZAR DE; JHEE SS; FULMOR IE; FORD N; SMITH RA; SRAMEK JJ
      PHARMACOKINETICS AND PHARMACODYNAMICS OF AVITRIPTAN IN PATIENTS WITH MIGRAINE AFTER ORAL DOSING

      Headache
    21. SAXENA PR; DEVRIES P; HEILIGERS JPC; BAX WA; VANDENBRINK AM; YOCCA FD
      BMS-181885, A 5-HT1B 1D RECEPTOR-LIGAND, IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL/

      European journal of pharmacology
    22. DEVRIES P; WILLEMS EW; HEILIGERS JPC; VILLALON CM; SAXENA PR
      THE ANTIMIGRAINE AGENT ALNIDITAN SELECTIVELY CONSTRICTS PORCINE CAROTID ARTERIOVENOUS ANASTOMOSES VIA 5-HT1B 1D RECEPTORS/

      European journal of pharmacology
    23. MacLennan, SJ; Cambridge, D; Whiting, MV; Marston, C; Martin, GR
      Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. LESAGE AS; WOUTERS R; VANGOMPEL P; HEYLEN L; VANHOENACKER P; HAEGEMAN G; LUYTEN WHML; LEYSEN JE
      AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES

      British Journal of Pharmacology
    25. GOADSBY PJ
      BENCH TO BEDSIDE - WHAT HAVE WE LEARNT RECENTLY ABOUT HEADACHE

      Current opinion in neurology
    26. MARANHAO PA; MARTINSFERREIRA H; VINCENT MB; RIBEIRO LJC; NOVIS SAP
      SUMATRIPTAN BLOCKS SPREADING DEPRESSION IN ISOLATED CHICK RETINA

      Cephalalgia
    27. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
      SUMATRIPTAN INHIBITS NEUROGENIC VASODILATION OF DURAL BLOOD-VESSELS IN THE ANESTHETIZED RAT - INTRAVITAL MICROSCOPE STUDIES

      Cephalalgia
    28. SCIBERRAS DG; POLVINO WJ; GERTZ BJ; CHENG HY; STEPANAVAGE M; WITTREICH J; OLAH T; EDWARDS M; MANT T
      INITIAL HUMAN-EXPERIENCE WITH MK-462 (RIZATRIPTAN) - A NOVEL 5-HT1D AGONIST

      British journal of clinical pharmacology
    29. SHEPHERD SL; WILLIAMSON DJ; BEER MS; HILL RG; HARGREAVES RJ
      DIFFERENTIAL-EFFECTS OF 5-HT1B 1D RECEPTOR AGONISTS ON NEUROGENIC DURAL PLASMA EXTRAVASATION AND VASODILATION IN ANESTHETIZED RATS/

      Neuropharmacology
    30. YU XJ; CUTRER FM; MOSKOWITZ MA; WAEBER C
      THE 5-HT1D RECEPTOR ANTAGONIST GR-127,935 PREVENTS INHIBITORY EFFECTSOF SUMATRIPTAN BUT NOT CP-122,288 AND 5-CT ON NEUROGENIC PLASMA EXTRAVASATION WITHIN GUINEA-PIG DURA-MATER

      Neuropharmacology
    31. TOTARO R; DEMATTEIS G; MARINI C; BALDASSARRE M; CAROLEI A
      SUMATRIPTAN AND CEREBRAL BLOOD-FLOW VELOCITY CHANGES DURING MIGRAINE ATTACKS

      Headache
    32. DIENER HC; GENDOLLA A; JUPTNER M; KAUBE H; LIMMROTH V
      EMERGING TREATMENTS IN HEADACHE

      European neurology
    33. GOADSBY PJ; KNIGHT Y
      INHIBITION OF TRIGEMINAL NEURONS AFTER INTRAVENOUS ADMINISTRATION OF NARATRIPTAN THROUGH AN ACTION AT 5-HYDROXYTRYPTAMINE (5-HT1B 1D) RECEPTORS/

      British Journal of Pharmacology
    34. CLAYTON JS; GASKIN PJ; BEATTIE DT
      ATTENUATION OF FOS-LIKE IMMUNOREACTIVITY IN THE TRIGEMINAL NUCLEUS CAUDALIS FOLLOWING TRIGEMINOVASCULAR ACTIVATION IN THE ANESTHETIZED GUINEA-PIG

      Brain research
    35. MCCALL RB
      TRIGEMINAL GANGLION ELICITED INCREASES IN NUCLEUS TRIGEMINAL CAUDALISBLOOD-FLOW - A NOVEL MIGRAINE MODEL

      Brain research
    36. LIMMROTH V; CUTRER M; MOSKOWITZ MA
      NEUROTRANSMITTERS AND NEUROPEPTIDES IN HEADACHE

      Current opinion in neurology
    37. LIMMROTH V; MAY A; DIENER HC
      THE VALUE OF SUMATRIPTAN IN THE ACUTE TRE ATMENT OF MIGRAINE AND CLUSTER HEADACHE

      Nervenheilkunde
    38. CUTLER NR; CLAGHORN J; SRAMEK JJ; BLOCK G; PANEBIANCO D; CHENG H; OLAH TV; REINES SA
      PILOT-STUDY OF MK-462 IN MIGRAINE

      Cephalalgia
    39. MAY A; GIJSMAN HJ; WALLNOFER A; JONES R; DIENER HC; FERRARI MD
      ENDOTHELIN ANTAGONIST BOSENTAN BLOCKS NEUROGENIC INFLAMMATION, BUT ISNOT EFFECTIVE IN ABORTING MIGRAINE ATTACKS

      Pain
    40. GOBEL H; STOLZE H; HEINZE A; DWORSCHAK M; HEUSS D; CHRISTIANI K; LINDNER V
      18-MONTH LONG-TERM ANALYSIS OF THE EFFECT IVENESS, SAFETY AND TOLERABILITY OF SUBCUTANEOUS SUMATRIPTAN IN ACUTE MIGRAINE TREATMENT

      Nervenarzt
    41. LIMMROTH V; MAY A; AUERBACH P; WOSNITZA G; EPPE T; DIENER HC
      CHANGES IN CEREBRAL BLOOD-FLOW VELOCITY AFTER TREATMENT WITH SUMATRIPTAN OR PLACEBO AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF MIGRAINE

      Journal of the neurological sciences
    42. MARTIN GR
      INHIBITION OF THE TRIGEMINO-VASCULAR SYSTEM WITH 5-HT1D AGONIST DRUGS- SELECTIVELY TARGETING ADDITIONAL SITES OF ACTION

      European neurology
    43. SAXENA PR; DEVRIES P; HEILIGERS JPC; VANDENBRINK AM; BAX WA; BARF T; WIKSTROM H
      INVESTIGATIONS WITH GMC2021 IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL

      European journal of pharmacology
    44. VISSER WH; BURGGRAAF J; MULLER LM; SCHOEMAKER RC; FOWLER PA; COHEN AF; FERRARI MD
      PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF SUMATRIPTAN IN MIGRAINE PATIENTS WITH HEADACHE RECURRENCE OR NO RESPONSE

      Clinical pharmacology and therapeutics
    45. HOSKIN KL; KAUBE H; GOADSBY PJ
      SUMATRIPTAN CAN INHIBIT TRIGEMINAL AFFERENTS BY AN EXCLUSIVELY NEURALMECHANISM

      Brain
    46. HOSKIN KL; KAUBE H; GOADSBY PJ
      CENTRAL ACTIVATION OF THE TRIGEMINOVASCULAR PATHWAY IN THE CAT IS INHIBITED BY DIHYDROERGOTAMINE - A C-FOS AND ELECTROPHYSIOLOGICAL STUDY

      Brain
    47. SANDLER M
      MIGRAINE TO THE YEAR 2000

      Cephalalgia
    48. BUZZI MG; BONAMINI M; MOSKOWITZ MA
      NEUROGENIC MODEL OF MIGRAINE

      Cephalalgia
    49. LIMMROTH V; WAEBER C; DIENER HC
      SUMATRIPTAN - UPDATE INFORMATION ON PHARM ACOLOGY, MECHANISM OF ACTION AND CLINICAL USE

      Aktuelle Neurologie
    50. STREET LJ; BAKER R; DAVEY WB; GUIBLIN AR; JELLEY RA; REEVE AJ; ROUTLEDGE H; STERNFELD F; WATT AP; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ; SOHAL B; GRAHAM MI; MATASSA VG
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF HYL-2-[5-(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL] ETHYLAMINE AND ANALOGS - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    51. KAJEKAR R; GUPTA P; SHEPPERSON NB; BRAIN SD
      EFFECT OF A 5-HT1 RECEPTOR AGONIST, CP-122,288, ON EDEMA FORMATION INDUCED BY STIMULATION OF THE RAT SAPHENOUS NERVE

      British Journal of Pharmacology
    52. DRAY A
      INFLAMMATORY MEDIATORS OF PAIN

      British Journal of Anaesthesia
    53. FERRARI MD; HAAN J; BLOKLAND JAK; ARNDT JW; MINNEE P; ZWINDERMAN AH; PAUWELS EKJ; SAXENA PR
      CEREBRAL BLOOD-FLOW DURING MIGRAINE ATTACKS WITHOUT AURA AND EFFECT OF SUMATRIPTAN

      Archives of neurology
    54. GOADSBY PJ
      DIAGNOSIS AND OPTIMUM TREATMENT OF MIGRAINE

      CNS DRUGS
    55. GOBEL H
      THE CURRENT POSITION OF SUMATRIPTAN IN MI GRAINE ATTACK THERAPY

      Nervenheilkunde
    56. HUMPHREY PPA; GOADSBY PJ
      THE MODE OF ACTION OF SUMATRIPTAN IS VASCULAR - A DEBATE

      Cephalalgia
    57. GOBEL H; KRAPAT S; DWORSCHAK M; HEUSS D; ENSINK FBM; SOYKA D
      EXTEROCEPTIVE SUPPRESSION OF TEMPORALIS MUSCLE-ACTIVITY DURING MIGRAINE ATTACK AND MIGRAINE INTERVAL BEFORE AND AFTER TREATMENT WITH SUMATRIPTAN

      Cephalalgia
    58. MARTELLETTI P; STIRPARO G; RINALDI C; FUSCO BM
      FUNCTION OF THE PERIPHERAL SEROTONINERGIC PATHWAYS IN MIGRAINE - A PROPOSAL FOR AN EXPERIMENTAL-MODEL

      Cephalalgia
    59. DIENER HC
      RECENT DEVELOPMENTS IN THE PATHOPHYSIOLOG Y AND TREATMENT OF HEADACHE

      Aktuelle Neurologie
    60. FACCHINETTI F; NAPPI RE; SANCES G; FIORONI L; NAPPI G; GENAZZANI AR
      THE NEUROENDOCRINE EFFECTS OF SUMATRIPTAN, A SPECIFIC LIGAND FOR 5-HT1-LIKE RECEPTORS

      Clinical endocrinology
    61. MARTELLETTI P; STIRPARO G; RINALDI C; GIACOVAZZO M
      UP-REGULATED EXPRESSION OF PERIPHERAL SEROTONERGIC RECEPTORS IN MIGRAINE AND CLUSTER HEADACHE BY SUMATRIPTAN

      International journal of clinical pharmacology research
    62. OSHAUGHNESSY CT; CONNOR HE
      ACTIVATION OF SENSORY NERVES IN GUINEA-PIG ISOLATED BASILAR ARTERY BYNICOTINE - EVIDENCE FOR INHIBITION OF TRIGEMINAL SENSORY NEUROTRANSMISSION BY SUMATRIPTAN

      European journal of pharmacology
    63. PLOSKER GL; MCTAVISH D
      SUMATRIPTAN - A REAPPRAISAL OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN THE ACUTE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE

      Drugs
    64. DAHLOF C; EKBOM K; PERSSON L
      CLINICAL-EXPERIENCES FROM SWEDEN ON THE USE OF SUBCUTANEOUSLY ADMINISTERED SUMATRIPTAN IN MIGRAINE AND CLUSTER HEADACHE

      Archives of neurology
    65. PANCONESI A; FRANCHI G; ANSELMI B; CURRADI C; TARQUINI B
      AMPLIFYING EFFECT OF SUMATRIPTAN ON NORADRENALINE VENOCONSTRICTION INMIGRAINE PATIENTS

      Cephalalgia
    66. TFELTHANSEN P
      SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE ATTACKS - A REVIEW OF CONTROLLED CLINICAL-TRIALS

      Cephalalgia
    67. FERRARI MD; SAXENA PR
      ON SEROTONIN AND MIGRAINE - A CLINICAL AND PHARMACOLOGICAL REVIEW

      Cephalalgia
    68. DEKEYSER J; VAUQUELIN G; DEBACKER JP; DEVOS H; WILCZAK N
      WHAT INTRACRANIAL TISSUES IN HUMANS CONTAIN SUMATRIPTAN-SENSITIVE SEROTONIN 5-HT1-TYPE RECEPTORS

      Neuroscience letters
    69. HENKES H; NAHSER HC; KLOTZSCH C; DIENER HC; KUHNE D
      ENDOVASCULAR DOPPLER ULTRASONOGRAPHY OF I NTRACRANIAL VESSELS - TECHNICAL NOTE AND POTENTIAL APPLICATIONS

      Radiologe
    70. PEROUTKA SJ
      5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES AND THE PHARMACOLOGY OF MIGRAINE

      Neurology
    71. GLOVER V; JARMAN J; SANDLER M
      MIGRAINE AND DEPRESSION - BIOLOGICAL ASPECTS

      Journal of Psychiatric Research
    72. KOBARI M; FUKUUCHI Y; TOMITA M; TANAHASHI N; KONNO S; TAKEDA H
      EFFECTS OF SUMATRIPTAN ON THE CEREBRAL INTRAPARENCHYMAL MICROCIRCULATION IN THE CAT

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 03:11:04